Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Alkem Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 1,918.85 4.45  | 0.23% -3.15% 28.28 22,902.68
NSE Price: Oct 17, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 17, 15:59 1,918.85 4.45 0.23% 1,915.85 1,914.40 12,463 1,891.05 - 1,926.80
BSE Oct 17, 2019 1,915.50 4.70 0.25% 1,910.85 1,910.80 405 1,890.00 - 1,927.60
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue5,942.605,714.095,281.014,548.233,951.04 3,137.562,708.40
Other Income60.9767.58100.91116.60251.28 182.13169.34
Total Income6,003.575,781.675,381.924,664.834,202.32 3,319.692,877.74
Total Expenditure4,812.094,668.384,307.613,670.243,231.27 2,792.052,295.62
Operating Profit1,191.481,113.291,074.31994.59971.05 527.64582.12
Interest26.9928.2632.3723.6858.67 72.6384.27
PBDT1,164.491,085.031,041.94970.91912.38 455.01497.84
Depreciation149.59141.07107.6576.4873.53 59.6842.73
PBT & Exceptional Items1,014.90943.96934.29894.43838.85 395.33455.11
Exceptional Items0.00---- --
Profit before Tax1,014.90943.96934.29894.43838.85 395.33455.11
Provision for Tax133.93144.12218.4511.27138.66 27.6411.01
Profit after Tax880.97799.84715.84883.16700.19 367.69444.10
 
LiabilitiesR Cr
Share Capital23.9123.9123.9123.9123.91 23.9111.96
Total Reserves5,441.305,441.304,861.454,368.743,575.59 3,080.692,778.04
Shareholder's Funds5,465.215,465.214,885.364,392.653,599.50 3,104.602,789.99
Long Term Borrowings6.326.326.330.000.00 28.1353.92
Other Non Current Liabilities178.06178.06135.8092.3568.62 125.0288.59
Current Liabilities1,642.561,642.561,786.681,413.351,154.29 1,603.051,299.56
Total Debt*-502.96547.52368.23380.27 1,102.54956.33
Total Liabilities7,292.157,292.156,814.175,898.354,822.41 4,860.804,232.07
 
AssetsR Cr
Net Block1,606.381,606.381,470.991,125.63874.68 870.46838.71
Non Current Investments1,476.421,476.421,203.421,225.64884.75 1,010.65609.83
Other Non-Current Assets1,128.671,128.671,108.071,279.05983.58 1,202.40574.93
Current Investments219.18219.18341.08292.00272.92 59.91330.96
Cash and Bank397.94397.94278.30199.06524.03 633.32890.81
Other Current Assets2,463.562,463.562,412.311,776.971,282.45 1,084.06986.84
Net Current Assets1,438.121,438.121,245.01854.68925.11 174.24909.04
Miscellaneous Exp. Not Written Off----- --
Total Assets7,292.157,292.156,814.175,898.354,822.41 4,860.804,232.07
 
Cash FlowR Cr
From Operations-742.85318.26499.06629.82 241.55105.81
From Investing Activities--310.82-273.11-361.90310.81 -259.8736.98
From Finance Activities--275.75-59.98-124.64-958.16 25.95-154.49
Net Inflow/Outflow-156.28-14.8312.52-17.53 7.63-11.70
 
Key Ratios
Adjusted EPS (Rs)73.6866.9059.8873.8758.57 30.7637.14
Adjusted Book Value (Rs)474.71457.15408.65367.43301.09 259.69233.35
Dividend per Share (Rs)-16.0013.0015.0012.70 4.004.00
Cash Flow per Share (Rs)-62.1426.6241.7452.68 20.2088.49
Debt to Equity0.000.090.110.080.11 0.360.34
Current Ratio1.881.881.701.601.80 1.111.70
ROCE (%)-17.0518.9721.0121.93 11.7714.66
RONW (%)17.0215.4515.4322.1020.89 12.4817.20
Operating Margin (%)20.0519.4820.3421.8724.58 16.8221.49
Net Margin (%)14.6713.8313.3018.9316.66 11.0815.43
Revenue Growth (%)9.858.2016.1115.1125.93 15.8516.35
Net Profit Growth (%)20.1511.73-18.9526.1390.43 -17.21-10.49
EPS Growth (%)20.1511.73-18.9526.1390.43 -17.20-10.49
Book Value Growth (%)-11.8711.2222.0415.94 11.2817.53
 
Market Cues
Close Price (Rs)1,918.851,750.851,988.352,204.901,356.45 --
High Price (Rs)1,997.052,268.002,469.002,227.951,588.90 --
Low Price (Rs)1,660.001,690.001,578.301,152.501,227.00 --
Market Cap (Rs Cr)22,902.6820,942.7723,635.0426,384.0916,336.51 0.000.00
Price / Earnings26.0026.1833.0229.8723.33 0.000.00
Price / Book Value4.043.834.846.014.54 0.000.00
Dividend Yield (%)0.840.910.660.680.93 --
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
7.77
Piotroski F-Score
8
Modified C-Score
0
3-Years Price to Earnings
28.28
3-Years Price to Book
4.07
Earnings Yield
EBIT / Enterprise value
4.56%
PEG
Price / Earnings to growth ratio
21.27
Related Stocks
  Current Price   Chng %
Abbott India R10,984.05 +0.32%
Biocon R258.05 -0.73%
Cadila Healthcare R237.80 +1.32%
Cipla R446.30 -0.11%
Glaxosmithkline Pharma R1,440.10 +0.76%
Lupin R726.50 -0.87%
Pfizer R3,195.65 +0.15%
Piramal Enterprises R1,468.85 +6.77%
Sanofi India R6,052.80 +1.21%
Torrent Pharmaceuticals R1,694.50 +3.19%
As on Oct 17, 15:59